MedPath

Pilot Study of Positive-End Expiratory Pressure in Acute Respiratory Distress Syndrome

Not Applicable
Completed
Conditions
Respiratory Distress Syndrome, Adult
Registration Number
NCT01119872
Lead Sponsor
Hospital Universitario Principe de Asturias
Brief Summary

Randomized controlled pilot trial in 70 patients with Acute Respiratory Distress Syndrome (ARDS) ventilated with low tidal volumes and limitation on airway pressure at 35 centimeters of water (cmH2O), to compare two different methods of selecting the level of Positive End-Expiratory Pressure (PEEP) to be applied: according to fraction of inspired oxygen (FiO2) needed or individualized according to the best compliance. Primary objective was evolution of arterial oxygenation during the 28 days. Secondary objectives were to measure its effects on hemodynamic parameters, 28-day mortality, number of ventilator-free days at day 28, Intensive Care Unit (ICU) and hospital stay, number of multiple-organ dysfunction-free days and a multivariate analysis of 28 day-mortality.

Detailed Description

In patients with Acute Respiratory Distress Syndrome the use of Positive End-Expiratory Pressure (PEEP) avoids atelectrauma, improves gas exchange and induces alveolar recruitment.Although it has side effects as inducing alveolar overdistension and circulatory depression.

There are several methods to determine the level of PEEP to be applied. We conducted a study to test the hypothesis that an individualized level of PEEP, set et the best compliance, when compared with a fixed level according to the fraction of inspired oxygen applied, improves oxygenation and reduces mortality rate at 28 days.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
70
Inclusion Criteria
  • Patients with Acute Respiratory Distress Syndrome (ARDS) according to the American-European Consensus Conference definition, after 24 hours under mechanical ventilation.
Exclusion Criteria
  • Younger than 18-year-old
  • Pregnancy
  • Neuromuscular diseases
  • Intracranial hypertension. Head trauma
  • Left ventricular dysfunction
  • Mechanical ventilation for more than 72 hours
  • Previous barotrauma
  • Patients with terminal stage of an illness and high risk of mortality within 90 days
  • Patients who refused to consent to the study

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Arterial Oxygenation28 days

Evolution of arterial oxygenation during the 28 days after study randomization

Secondary Outcome Measures
NameTimeMethod
Mortality28 days

Mortality 28 days after randomization

Number of ventilator-free days at day 2828 days

Number of ventilator-free days at day 28 after randomization

multivariate analysis of mortality28 days

Trial Locations

Locations (1)

Critical Care Unit. Universitary Hospital Principe de Asturias

🇪🇸

Alcalá de Henares, Madrid, Spain

Critical Care Unit. Universitary Hospital Principe de Asturias
🇪🇸Alcalá de Henares, Madrid, Spain

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.